BERG Health
Curated by SignalDiagnostics, theranostics & therapeutics using proprietary drug discovery platform
Overview
Berg health is engaged in the research and development of diagnostics, theranostics, and therapeutics in the areas of oncology, endocrinology, and neurology. It is using its own Interrogative Biology & platform for research which is a combination of systems biology and Artificial Intelligence. It is evaluating BPM 31510 as a single agent and in combination with gemcitabine, 5FU, or docetaxel in patients with advanced refractory solid tumors. Also evaluating if topical Calcitriol (BPM 31543) is effective in preventing and/or diminishing chemotherapy-induced alopecia. It is developing diagnostic assays for prostate cancer and heart failure. It is discovering drugs for Parkinson, Alzheimer's, Diabetes, and Solid Tumors.
Key facts
- Founded
- 2006
- Headquarters
- Framingham, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Contact
- Primary office
- Sign up to view